T1	Age 25 28	Age
E1	Age:T1 Eq-Comparison:E2
T2	Eq-Comparison 32 48	50 years or over
E2	Eq-Comparison:T2 Value:T68 Temporal-Unit:T69 Operator:T70
T3	Eq-Comparison 55 75	Scheduled to undergo
E3	Eq-Comparison:T3 Temporal-Period:T71
T5	Or 81 83	or
E5	Or:T5 Arg:E4 Arg2:E6
T7	Modifier 105 120	upper abdominal
E7	Modifier:T7 Modifies:T75
T8	Or 121 123	or
E8	Or:T8 Arg:E7 Arg2:E68
T9	Procedure 138 145	surgery
E9	Procedure:T9 Name:T75 Temporality:E3
T10	Assertion 156 164	expected
E10	Assertion:T10 Asserted:E11
A1	Assertion-Type-Value E10 hypothetical
T11	Procedure 177 184	surgery
E11	Procedure:T11 Name:T76 Duration:E12
T12	Eq-Comparison 188 205	2 hours or longer
E12	Eq-Comparison:T12 Value:T77 Temporal-Unit:T78 Operator:T79
T13	Risk 231 235	risk
E13	Risk:T13 Polarity:T80 Risk-For:E14
T14	Condition 239 243	PPCs
E14	Condition:T14 Name:T81
T15	Observation 261 279	ARISCAT risk score
E15	Observation:T15 Name:T82
T16	Eq-Comparison 300 309	score ≥45
E16	Eq-Comparison:T16 Value:T84 Operator:T74
T17	Condition 337 374	American Society of Anesthesiologists
E17	Condition:T17 Name:T85
T18	Condition 376 379	ASA
E18	Condition:T18 Name:T86 Stage:E19
T19	Eq-Comparison 390 409	classification ≥ IV
E19	Eq-Comparison:T19 Unit:T87 Operator:T88 Value:T89
T20	Or 410 412	or
E20	Or:T20 Arg:E18 Arg2:E21
T21	Observation 417 434	expected survival
E21	Observation:T21 Name:T133 Eq-Comparison:E22
T22	Eq-Comparison 444 450	≤ 24 h
E22	Eq-Comparison:T22 Operator:T90 Value:T91 Temporal-Unit:T92
T23	Temporal-Connection 457 460	Pre
E23	Temporal-Connection:T23 Arg:E70 Arg2:E25
A2	Temporal-Connection-Type-Value E23 before
T24	Eq-Comparison 470 477	history
E24	Eq-Comparison:T24 Temporal-Period:T93
T25	Condition 481 502	prostatic hypertrophy
E25	Condition:T25 Name:T94 Temporality:E24
T26	Or 503 505	or
E26	Or:T26 Arg:E25 Arg2:E27
T27	Condition 506 514	glaucoma
E27	Condition:T27 Name:T95
T28	Eq-Comparison 521 528	History
E28	Eq-Comparison:T28 Temporal-Period:T96
T29	Condition 532 553	myocardial infarction
E29	Condition:T29 Name:T97 Temporality:E28
T30	Condition 562 579	heart dysfunction
E30	Condition:T30 Name:T99 Severity:T98
T31	Condition 581 618	New York Heart Association functional
E31	Condition:T31 Name:T100 Stage:E32
T32	Eq-Comparison 619 637	classification ≥ 3
E32	Eq-Comparison:T32 Operator:T101 Value:T102
T33	Or 639 641	or
E33	Or:T33 Arg:E30 Arg2:E34
T34	Condition 642 657	tachyarrhythmia
E34	Condition:T34 Name:T136 Temporality:E35
T35	Eq-Comparison 658 673	within one year
E35	Eq-Comparison:T35 Operator:T103 Value:T104 Temporal-Unit:T105
T36	Drug 694 715	β2-receptor activator
E36	Drug:T36 Name:T106
T37	Drug 717 736	M-receptor blockers
E37	Drug:T37 Name:T107
T38	Or 737 743	and/or
E38	Or:T38 Arg:E37 Arg2:E39
T39	Drug 744 759	glucocorticoids
E39	Drug:T39 Name:T108 Temporality:E40
T40	Eq-Comparison 760 776	within one month
E40	Eq-Comparison:T40 Operator:T109 Value:T110 Temporal-Unit:T111
T41	Temporal-Connection 777 783	before
E41	Temporal-Connection:T41 Arg:E40 Arg2:E42
A3	Temporal-Connection-Type-Value E41 before
T42	Procedure 784 791	surgery
E42	Procedure:T42 Name:T112
T43	Condition 805 822	renal dysfunction
E43	Condition:T43 Name:T114 Severity:T113
T44	Assertion 824 835	requirement
E44	Assertion:T44 Asserted:E45
A4	Assertion-Type-Value E44 hypothetical
T45	Procedure 839 864	renal replacement therapy
E45	Procedure:T45 Name:T115
T46	Or 866 868	or
E46	Or:T46 Arg:E43 Arg2:E47
T47	Condition 876 895	hepatic dysfunction
E47	Condition:T47 Name:T117 Severity:T116
T48	Observation 897 907	Child-Pugh
E48	Observation:T48 Name:T118 Eq-Comparison:E49
T49	Eq-Comparison 908 915	grade C
E49	Eq-Comparison:T49 Unit:T119 Value:T120
T50	Eq-Comparison 923 930	History
E50	Eq-Comparison:T50 Temporal-Period:T121
T51	Condition 940 946	stroke
E51	Condition:T51 Name:T123 Severity:T122 Temporality:E50 Temporality2:E52
T52	Eq-Comparison 947 966	within three months
E52	Eq-Comparison:T52 Operator:T124 Value:T125 Temporal-Unit:T126
T53	Temporal-Connection 967 973	before
E53	Temporal-Connection:T53 Arg:E52 Arg2:E54
A5	Temporal-Connection-Type-Value E53 before
T54	Procedure 974 981	surgery
E54	Procedure:T54 Name:T127
T55	Assertion 988 997	Refuse to
E55	Assertion:T55 Asserted:E56
A6	Assertion-Type-Value E55 hypothetical
T56	Study 1017 1022	study
E56	Study:T56 
T57	Procedure 1055 1073	inhalation therapy
E57	Procedure:T57 Name:T128
T58	Other 1097 1102	other
E58	Other:T58 Is-Other:E59
T59	Study 1103 1117	clinical trial
E59	Study:T59 
T60	Temporal-Connection 1118 1124	during
E60	Temporal-Connection:T60 Arg:E59 Arg2:E61
A7	Temporal-Connection-Type-Value E60 during
T61	Eq-Comparison 1129 1139	last month
E61	Eq-Comparison:T61 Temporal-Period:T129 Temporal-Unit:T130
T62	Or 1140 1142	or
E62	Or:T62 Arg:E61 Arg2:E63
T63	Eq-Comparison 1143 1167	within the six half-life
E63	Eq-Comparison:T63 Value:T131 Unit:T132
T64	Temporal-Connection 1168 1175	periods
E64	Temporal-Connection:T64 Arg:E63 Arg2:E65
A8	Temporal-Connection-Type-Value E64 before
T65	Study 1183 1188	study
E65	Study:T65 Study-Of:E66
T66	Drug 1189 1193	drug
E66	Drug:T66 
T67	Study 1211 1216	trial
E67	Study:T67 Temporality:E74
T68	Eq-Value 32 34	50
T69	Eq-Temporal-Unit 35 40	years
A9	Eq-Temporal-Unit-Value T69 year
T70	Eq-Operator 41 48	or over
A10	Eq-Operator-Value T70 GTEQ
T71	Eq-Temporal-Period 55 75	Scheduled to undergo
A11	Eq-Temporal-Period-Value T71 future
T75	Procedure-Name 138 145	surgery
T76	Procedure-Name 177 184	surgery
T77	Eq-Value 188 189	2
T78	Eq-Temporal-Unit 190 195	hours
A13	Eq-Temporal-Unit-Value T78 hour
T79	Eq-Operator 196 205	or longer
A14	Eq-Operator-Value T79 GTEQ
T80	Polarity 226 230	high
A15	Polarity-Value T80 high
T81	Condition-Name 239 243	PPCs
T82	Observation-Name 261 279	ARISCAT risk score
A16	Observation-Type-Value T82 clinical-score
T83	Observation-Name 281 305	ARISCAT predictive score
A17	Observation-Type-Value T83 clinical-score
T84	Eq-Value 307 309	45
T85	Condition-Name 337 374	American Society of Anesthesiologists
T86	Condition-Name 376 379	ASA
T87	Eq-Unit 390 404	classification
T88	Eq-Operator 405 406	≥
A18	Eq-Operator-Value T88 GTEQ
T89	Eq-Value 407 409	IV
T90	Eq-Operator 444 445	≤
A19	Eq-Operator-Value T90 LTEQ
T91	Eq-Value 446 448	24
T92	Eq-Temporal-Unit 449 450	h
A20	Eq-Temporal-Unit-Value T92 hour
T93	Eq-Temporal-Period 470 477	history
A21	Eq-Temporal-Period-Value T93 past
T94	Condition-Name 481 502	prostatic hypertrophy
T95	Condition-Name 506 514	glaucoma
T96	Eq-Temporal-Period 521 528	History
A22	Eq-Temporal-Period-Value T96 past
T97	Condition-Name 532 553	myocardial infarction
T98	Severity 555 561	severe
A23	Severity-Value T98 severe
T99	Condition-Name 562 579	heart dysfunction
T100	Condition-Name 581 618	New York Heart Association functional
T101	Eq-Operator 634 635	≥
A24	Eq-Operator-Value T101 GTEQ
T102	Eq-Value 636 637	3
T103	Eq-Operator 658 664	within
A25	Eq-Operator-Value T103 LTEQ
T104	Eq-Value 665 668	one
T105	Eq-Temporal-Unit 669 673	year
A26	Eq-Temporal-Unit-Value T105 year
T106	Drug-Name 694 715	β2-receptor activator
T107	Drug-Name 717 736	M-receptor blockers
T108	Drug-Name 744 759	glucocorticoids
T109	Eq-Operator 760 766	within
A27	Eq-Operator-Value T109 LTEQ
T110	Eq-Value 767 770	one
T111	Eq-Temporal-Unit 771 776	month
A28	Eq-Temporal-Unit-Value T111 month
T112	Procedure-Name 784 791	surgery
T113	Severity 798 804	Severe
A29	Severity-Value T113 severe
T114	Condition-Name 805 822	renal dysfunction
T115	Procedure-Name 839 864	renal replacement therapy
T116	Severity 869 875	severe
A30	Severity-Value T116 severe
T117	Condition-Name 876 895	hepatic dysfunction
T118	Observation-Name 897 907	Child-Pugh
T119	Eq-Unit 908 913	grade
T120	Eq-Value 914 915	C
T121	Eq-Temporal-Period 923 930	History
A31	Eq-Temporal-Period-Value T121 past
T122	Severity 934 939	acute
A32	Severity-Value T122 severe
T123	Condition-Name 940 946	stroke
T124	Eq-Operator 947 953	within
A33	Eq-Operator-Value T124 LTEQ
T125	Eq-Value 954 959	three
T126	Eq-Temporal-Unit 960 966	months
A34	Eq-Temporal-Unit-Value T126 month
T127	Procedure-Name 974 981	surgery
T128	Procedure-Name 1055 1073	inhalation therapy
T129	Eq-Temporal-Period 1129 1133	last
A35	Eq-Temporal-Period-Value T129 past
T130	Eq-Temporal-Unit 1134 1139	month
A36	Eq-Temporal-Unit-Value T130 month
T131	Eq-Value 1154 1157	six
T132	Eq-Unit 1158 1167	half-life
T4	Modifier 76 80	open
E4	Modifier:T4 Modifies:T75
T6	Modifier 84 104	laparoscope assisted
E6	Modifier:T6 Modifies:T75
T72	Modifier 124 137	intrathoracic
E68	Modifier:T72 Modifies:T75
T73	Observation 281 305	ARISCAT predictive score
E69	Observation:T73 Name:T83 Eq-Comparison:E16
T74	Eq-Operator 306 307	≥
A12	Eq-Operator-Value T74 GTEQ
R1	Equivalent-To Arg1:E69 Arg2:E15	
R2	Found-By Arg1:E13 Arg2:E15	
R3	Abbrev-Of Arg1:E18 Arg2:E17	
T133	Observation-Name 417 434	expected survival
T134	Procedure 460 469	operative
E70	Procedure:T134 Name:T135
T135	Procedure-Name 460 469	operative
R4	Equivalent-To Arg1:E31 Arg2:E30	
T136	Condition-Name 642 657	tachyarrhythmia
R5	Treatment-For Arg1:E45 Arg2:E43	
A37	Observation-Type-Value T118 clinical-score
R6	Equivalent-To Arg1:E48 Arg2:E47	
T137	Assertion 1026 1032	unable
E71	Assertion:T137 Asserted:E72
A38	Assertion-Type-Value E71 hypothetical
T138	Negation 1026 1032	unable
E72	Negation:T138 Negates:E57
T139	Or 1023 1025	or
E73	Or:T139 Arg:E56 Arg2:E71
T140	Eq-Comparison 1206 1210	last
E74	Eq-Comparison:T140 Temporal-Recency:T141
T141	Eq-Temporal-Recency 1206 1210	last
A39	Eq-Temporal-Recency-Value T141 most-recent-time
T142	Temporal-Connection 1194 1201	used in
E75	Temporal-Connection:T142 Arg:E66 Arg2:E74
A40	Temporal-Connection-Type-Value E75 during
